
GLP-1 Weight-Loss Drugs Reveal Hidden Costs Beyond the Scale
A BuzzFeed Health feature examines how GLP-1 weight-loss medications (like Ozempic, Wegovy and Mounjaro) marketed for medical use are being used cosmetically, triggering a viral Reddit thread about a partner whose two-year Ozempic journey left her with a gaunt appearance, muscle loss, debt, and relationship strain. The piece highlights easy access via telehealth, aggressive marketing, and the risk of body dysmorphia or eating disorders when medical safeguards are bypassed. It emphasizes that these drugs are not miracle cures and should be paired with resistance training and adequate protein, while urging professional support for underlying psychological issues and broader societal pressures around body image.












